Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by HighteawithIntrepidon Jun 18, 2017 9:58am
133 Views
Post# 26375196

June 5 plus 13

June 5 plus 13Reality bites. Still mad that they didn't do a
rights offering but until Tuesday they have a shot
at positive FDA news. The prospectus will list the
other houses acting as secondary players.
Anyone ask Fred why they didn't do a rights offering?
Feeling less alone as a few more believers are sounding 
more like conscripts. The fact we are here and posting and
not burnt in the London Fire or shot in the US is a reason
to be thankful. So as one of late night guy used to say
" May your God go with you". Enjoy the day. HT
Bullboard Posts